イリノイ州における肝臓がんの臨床試験
イリノイ州内の拠点で、肝臓がんに関する11件の研究が参加者を募集しています。
イリノイ州内の都市
公式研究テキスト（英語）
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
- Memorial Hospital, Shiloh
- Siteman Cancer Center - Shiloh, Shiloh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07227012National Liver Cancer Screening Trial
- Northwestern University, Chicago
被験者募集中第4相
18歳〜85歳 · 全性別 · 2026/09/25更新 · NCT06084234A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- University of Chicago Medical Center /ID# 270517, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06858813Defining the Ablative Dose for Y-90 TARE
- Northwestern University, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07586046CREO - Microwave Ablation Feasibility Study
- Rush University Medical Center, Chicago
被験者募集中
18歳以上 · 全性別 · 2026/09/14更新 · NCT07817147Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
- RUSH University Medical Center, Chicago
- University of Chicago, Chicago
被験者募集中観察研究
22歳以上 · 全性別 · 2026/09/11更新 · NCT06486454DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Rush University Medical Center, Chicago
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/21更新 · NCT07717437Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/17更新 · NCT06600321SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。